Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Jen Liu

Showing results (221-230 of 400) with videos related to

Pageof 40
Sort By:
Journal of Gastroenterology|June 6, 2013
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapyTung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2023
Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis BPin-Nan Cheng, I-Cher Feng, Jyh-Jou Chen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2017
Synergistic Effect of Hyperglycemia and Helicobacterpylori Infection Status on Colorectal Adenoma RiskKuang-Chun Hu, Ming-Shiang Wu, Cheng-Hsin Chu, et al.
Gut|November 12, 2010
Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2Mei-Hsuan Lee, Hwai-I Yang, Chin-Lan Jen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort studyMei-Hsuan Lee, Hwai-I Yang, Sheng-Nan Lu, et al.
Gastroenterology|May 29, 2008
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in TaiwanChi-Ling Chen, Hwai-I Yang, Wei-Shiung Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 29, 2024
Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapyKai-Chun Chang, Tung-Hung Su, Sih-Han Liao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2010
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis CChen-Hua Liu, Cheng-Chao Liang, Chun-Jen Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2007
Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance indexChen-Hua Liu, Shih-Jer Hsu, Jou-Wei Lin, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2019
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myelomaTung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, et al.
Pageof 40

Showing results (221-230 of 400) with videos related to

Sort By:
Pageof 40
Journal of Gastroenterology|June 6, 2013
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapyTung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2023
Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis BPin-Nan Cheng, I-Cher Feng, Jyh-Jou Chen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2017
Synergistic Effect of Hyperglycemia and Helicobacterpylori Infection Status on Colorectal Adenoma RiskKuang-Chun Hu, Ming-Shiang Wu, Cheng-Hsin Chu, et al.
Gut|November 12, 2010
Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2Mei-Hsuan Lee, Hwai-I Yang, Chin-Lan Jen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort studyMei-Hsuan Lee, Hwai-I Yang, Sheng-Nan Lu, et al.
Gastroenterology|May 29, 2008
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in TaiwanChi-Ling Chen, Hwai-I Yang, Wei-Shiung Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 29, 2024
Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapyKai-Chun Chang, Tung-Hung Su, Sih-Han Liao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2010
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis CChen-Hua Liu, Cheng-Chao Liang, Chun-Jen Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2007
Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance indexChen-Hua Liu, Shih-Jer Hsu, Jou-Wei Lin, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2019
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myelomaTung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, et al.
Pageof 40